Evolus Inc (EOLS)

Jun 03, 2025

EOLS Set to Participate in BTIG's Virtual Meeting on June 9 | EO - GuruFocus

Jun 03, 2025

Jun 02, 2025

Evolus Launches Second Product Line for Wrinkles - Orange County Business Journal

Jun 02, 2025

Jun 01, 2025

Evolus boosts balance sheet with lower-cost refinancing and flexibility - MSN

Jun 01, 2025

May 30, 2025

Evolus announces CFO resignation - MSN

May 30, 2025

May 30, 2025

Stifel maintains Evolus stock buy rating, $25 target - Investing.com Australia

May 30, 2025

May 30, 2025

Midday Stock Roundup: Activist Investor Targets El Pollo Loco - Orange County Business Journal

May 30, 2025

May 30, 2025

Stifel maintains Evolus stock buy rating, $25 target By Investing.com - Investing.com Nigeria

May 30, 2025

May 30, 2025

Increases to CEO Compensation Might Be Put On Hold For Now at Evolus, Inc. (NASDAQ:EOLS) - simplywall.st

May 30, 2025

May 28, 2025

Mizuho maintains Evolus stock Outperform rating and $25 target By Investing.com - Investing.com India

May 28, 2025

May 28, 2025

Evolus CFO Sandra Beaver resigns for new role By Investing.com - Investing.com South Africa

May 28, 2025

May 28, 2025

Mizuho maintains Evolus stock Outperform rating and $25 target - Investing.com

May 28, 2025

May 27, 2025

Evolus CFO to Resign - Orange County Business Journal

May 27, 2025

May 27, 2025

Evolus CFO Sandra Beaver Resigns - marketscreener.com

May 27, 2025

May 27, 2025

Evolus (EOLS) CFO Resignation Announced - GuruFocus

May 27, 2025

May 27, 2025

Evolus CFO Sandra Beaver Announces Resignation - TipRanks

May 27, 2025

May 27, 2025

Resignation of CFO Impacts Evolus (EOLS) Leadership | EOLS Stock News - GuruFocus

May 27, 2025

May 27, 2025

Evolus Announces Departure of its Chief Financial Officer | EOLS Stock News - GuruFocus

May 27, 2025

May 27, 2025

Evolus announces departure of CFO Sandra Beaver - TipRanks

May 27, 2025

May 27, 2025

Evolus CFO Sandra Beaver resigns for new role - Investing.com

May 27, 2025

May 27, 2025

Evolus Announces Departure Of Its Chief Financial Officer - marketscreener.com

May 27, 2025

May 27, 2025

Evolus Announces Departure of its Chief Financial Officer - Business Wire

May 27, 2025

May 22, 2025

Evolysse HA gels outperform Restylane in clinical study - Investing.com Australia

May 22, 2025

May 22, 2025

Evolus Announces Publication of U.S. Pivotal Study for Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels - marketscreener.com

May 22, 2025

May 22, 2025

Evolus announces publication of U.S. pivotal study for Evolysse injectable gels - TipRanks

May 22, 2025

May 22, 2025

EOLS Publishes Promising Study Results on Evolysse Injectable Gels | EOLS Stock News - GuruFocus

May 22, 2025

May 22, 2025

Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels - BioSpace

May 22, 2025

May 22, 2025

Evolysse HA gels outperform Restylane in clinical study By Investing.com - Investing.com Canada

May 22, 2025

May 22, 2025

Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ - GuruFocus

May 22, 2025

May 22, 2025

Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels | EOLS Stock News - GuruFocus

May 22, 2025

May 22, 2025

Trend Tracker for (EOLS) - news.stocktradersdaily.com

May 22, 2025

May 21, 2025

Deutsche Bank AG Cuts Stock Holdings in Evolus, Inc. (NASDAQ:EOLS) - Defense World

May 21, 2025

May 17, 2025

Comerica Bank Purchases New Stake in Evolus, Inc. (NASDAQ:EOLS) - Defense World

May 17, 2025

May 16, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to 16 newly hired non-executive employees - BioSpace

May 16, 2025

May 16, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News - GuruFocus

May 16, 2025

May 16, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 16, 2025

May 16, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

May 16, 2025

May 14, 2025

Evolus Executives Sell Shares to Cover Tax Obligations - TradingView

May 14, 2025

May 14, 2025

Evolus, Inc. (NASDAQ:EOLS) Shares Sold by Voya Investment Management LLC - Defense World

May 14, 2025

May 13, 2025

Evolus, Inc. (EOLS): A Bull Case Theory - Insider Monkey

May 13, 2025

May 10, 2025

Evolus (NASDAQ:EOLS) Earns Buy Rating from Needham & Company LLC - Defense World

May 10, 2025

May 10, 2025

Evolus projects $345M-$355M revenue for 2025 with new product launches - MSN

May 10, 2025

May 10, 2025

Analyst Estimates: Here's What Brokers Think Of Evolus, Inc. (NASDAQ:EOLS) After Its First-Quarter Report - simplywall.st

May 10, 2025

May 10, 2025

Evolus, Inc. (NASDAQ:EOLS) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Yahoo

May 10, 2025

May 09, 2025

Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Arcus Biosciences (RCUS) - The Globe and Mail

May 09, 2025

May 08, 2025

Evolus, Inc. Reports Strong Q1 Growth Amid Challenges - TipRanks

May 08, 2025

May 08, 2025

EOLS Stock: Needham Reiterates Buy Rating with $22 Target | EOLS Stock News - GuruFocus

May 08, 2025

May 08, 2025

Evolus, Inc. (NASDAQ:EOLS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025

May 08, 2025

What Analysts Are Saying About Evolus Stock - Benzinga

May 08, 2025

May 08, 2025

Evolus Inc (EOLS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo Finance

May 08, 2025

May 08, 2025

Evolus Inc (EOLS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges By GuruFocus - Investing.com Canada

May 08, 2025

May 08, 2025

Evolus, Inc. Reports Strong Q1 2025 Growth - TipRanks

May 08, 2025